ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Celgene's Revlimid tops Medicare spending, shares the price-hike title with Pfizer's Lyrica
March 18, 2019One cancer drug, two diabetes drugs and two next-generation blood thinners topped the Medicare Part D charts for 2017—all with sales of more than $2.5 billion apiece. But two other numbers stood out at the top of the list: the 15%-plus price increases for
Pharma Sources Insight January 2025
